Global Leading Market Research Publisher QYResearch announces the release of its latest report *”Radiation Therapy Information & Image Management Software – Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032″*. Based on current situation and impact historical analysis (2021-2025) and forecast calculations (2026-2032), this report provides a comprehensive analysis of the global Radiation Therapy Information & Image Management Software market, including market size, share, demand, industry development status, and forecasts for the next few years.
For oncology departments and radiotherapy centers, the clinical challenge is no longer just about delivering precise radiation doses—it is about managing fragmented patient data across treatment planning systems (TPS), electronic medical records (EMR), imaging archives (PACS), and linear accelerator (LINAC) logs. Radiation Therapy Information & Image Management Software (RT I&IM) solves this by unifying diagnosis data, treatment plans, imaging studies, equipment control logs, and quality assurance records into a single digital workflow. The global market for this software was estimated at US$ 1,484 million in 2025 and is projected to reach US$ 2,508 million by 2032, growing at a robust CAGR of 7.9% from 2026 to 2032. This growth is driven by the rising global cancer incidence (estimated 20 million new cases annually), the shift toward value-based oncology care, and regulatory pressure for complete radiotherapy treatment documentation.
【Get a free sample PDF of this report (Including Full TOC, List of Tables & Figures, Chart)】
https://www.qyresearch.com/reports/6095045/radiation-therapy-information—image-management-software
1. Technical Definition and Core Functional Pillars
Radiation Therapy Information & Image Management Software is an information system purpose-built for the tumor radiotherapy process. It integrates patient diagnosis and treatment data, treatment plans, imaging data, equipment control records, and quality control logs to achieve digital, automated, and standardized management of the entire radiotherapy care continuum. The core functional pillars include:
- Patient Registration & Scheduling: Centralized intake, appointment coordination across LINACs, CT simulators, and brachytherapy suites.
- Treatment Planning Integration: Bi-directional data exchange with TPS (e.g., Eclipse, Monaco, RayStation) for plan approval, version control, and dose tracking.
- Image Management: Storage and retrieval of CT, MRI, PET, and CBCT images with DICOM-RT compliance, including structure sets, dose distributions, and treatment images.
- Treatment Delivery Logging: Automated capture of beam-on time, monitor units, patient positioning data, and machine parameters from LINACs (Varian TrueBeam, Elekta Versa HD).
- Quality Assurance & Safety: Machine QA scheduling, chart checking, incident reporting, and fail-safe verification (e.g., pre-treatment plan checks, physics chart audits).
- Reporting & Analytics: Compliance reporting (ASTRO, ROPA), outcome tracking, and operational dashboards for utilization and wait times.
2. Market Segmentation and Vendor Landscape
The Radiation Therapy Information & Image Management Software market is segmented as follows:
By Deployment Model:
- On-Premises: Traditional model, preferred by large academic medical centers and cancer hospitals with existing IT infrastructure and data sovereignty requirements. Still accounts for approximately 65% of installed base as of 2025.
- Cloud-Based: Rapidly growing segment (projected 32% CAGR 2026-2032), driven by community oncology practices, multi-site networks, and the need for disaster recovery, remote physics support, and vendor-managed updates.
By End User:
- Medical Institutions (hospitals, cancer centers, free-standing clinics) – largest segment, >80% revenue share
- Research & Teaching (academic radiotherapy departments, clinical trial coordinators)
- Others (military treatment facilities, veterinary oncology centers)
Key Vendors (Active Q4 2025 – Q1 2026):
The market remains moderately consolidated, with Varian Medical (now Siemens Healthineers) and Elekta holding >55% combined share, leveraging their LINAC installed base to drive RT I&IM adoption. Other significant players include RaySearch (treatment planning and oncology information systems), Philips, GE HealthCare (imaging integration), Brainlab (neurosurgery and radiosurgery workflow), Mirada Medical (advanced image registration and contouring), Accuray (CyberKnife and TomoTherapy), IBA Group (proton therapy workflow), DOSIsoft, LAP, Medron Medical, Sun Nuclear (QA integration), PTW Freiburg, ScandiDos, AQUILAB, Comecer, and China-based Yaozhi Medical Device Data and Super Accuracy (Beijing) Technology – the latter two gaining traction in APAC with cost-optimized, cloud-native solutions.
3. Recent Industry Data and Technology Inflection Points (Last 6 Months)
- AI-Powered Auto-Contouring Integration (Q3 2025): Mirada Medical and RaySearch launched deep learning-based auto-segmentation modules directly embedded within RT I&IM dashboards, reducing organ-at-risk contouring time from 45 minutes to under 5 minutes per case. A multi-center study (European Society for Radiotherapy and Oncology, September 2025) reported 94% clinical acceptability for AI-generated contours.
- Cloud Adoption Surge in Community Oncology (Q4 2025): US-based community oncology provider network (21 sites) migrated from legacy on-premises RT I&IM to a cloud-native platform from Elekta (MOSAIQ® Cloud). Within 6 months, they reduced IT overhead by 38%, enabled remote physics coverage across 3 time zones, and achieved real-time treatment log aggregation for value-based reporting.
- DICOM-RT Validation and Interoperability Mandates: The American College of Radiology (ACR) updated its Practice Parameter for Radiation Oncology (effective January 2026) requiring complete DICOM-RT object retention (including dose volumes and treatment records) for at least 10 years. This directly boosts demand for Radiation Therapy Information & Image Management Software with automated archival and integrity checking.
- Proton Therapy Workflow Expansion: With 45 new proton therapy centers under construction globally (as of December 2025), vendors like IBA Group and Varian are requiring RT I&IM solutions that handle pencil beam scanning logs, daily QA, and adaptive replanning workflows—distinct from conventional photon-based LINAC workflows.
4. Exclusive Analyst Observation – Workflow vs. Process Automation Analogy
In manufacturing, discrete manufacturing (e.g., medical device assembly) requires tracking individual units through distinct stations, while process manufacturing (e.g., pharmaceutical production) demands continuous batch monitoring and recipe control. In radiotherapy, the parallel is clear: Radiation Therapy Information & Image Management Software must handle both discrete-like patient episodes (each patient as a unique “unit” with personalized plan, imaging series, and QA checks) and process-like continuous data streams (LINAC beam logs, daily machine output, real-time imaging feedback). Most legacy RT I&IM systems excel at discrete patient tracking but struggle with real-time process data ingestion. The next-generation systems (e.g., Varian’s Ethos™ workflow integration, RayCare®) are now unifying both paradigms using FHIR-based APIs and time-series databases.
5. Policy Timelines and Technical Challenges
- EU Medical Device Regulation (MDR) Deadline (May 2026): All software used in clinical decision support, including RT I&IM, must achieve Class IIa or IIb certification. Vendors without updated technical documentation face market access restrictions in Europe.
- China NMPA Cybersecurity Mandate (effective Q2 2026): Cloud-based Radiation Therapy Information & Image Management Software must store patient data on domestic servers and undergo annual security audits. Local vendors (Yaozhi, Super Accuracy) have competitive advantages.
- Technical Challenge – Real-Time Adaptive Radiotherapy: Online adaptive radiotherapy (where plans are modified daily based on anatomy changes) requires RT I&IM to support sub-10-minute plan re-optimization, contour propagation, and QA verification—pushing current database architectures to their limits.
Contact Us:
If you have any queries regarding this report or if you would like further information, please contact us:
QY Research Inc.
Add: 17890 Castleton Street Suite 369 City of Industry CA 91748 United States
EN: https://www.qyresearch.com
E-mail: global@qyresearch.com
Tel: 001-626-842-1666(US)
JP: https://www.qyresearch.co.jp
